Dr. Leah Rae Griggs, M.D. Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 484 Golden Autumn Way Ste 201, Bowling Green, KY 42103 Phone: 270-781-5111 Fax: 270-780-0475 |
Dr. Avinash Aravantagi, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 484 Golden Autumn Way Ste 201, Bowling Green, KY 42103 Phone: 270-781-5111 Fax: 270-780-0475 |
Dr. Cory M. Fielding, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 484 Golden Autumn Way Ste 201, Bowling Green, KY 42103 Phone: 290-393-2759 Fax: 270-780-0475 |
Dr. Nagy H Morsi, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1701 Ashley Cir, Suite 100, Bowling Green, KY 42104 Phone: 270-796-6000 Fax: 270-796-1915 |
Robert Emslie, M.D. Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 350 Park St, Bowling Green, KY 42101 Phone: 270-781-5111 Fax: 270-780-0478 |
Aswathi Chandran, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 484 Golden Autumn Way Ste 201, Bowling Green, KY 42103 Phone: 270-393-4892 Fax: 270-780-0475 |
Dr. Abrar M Arshad, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 421 Us 31w Byp, Bowling Green, KY 42101 Phone: 270-393-9829 Fax: 270-393-9830 |
Dr. Morteza Shahmir, M.D. Internal Medicine - Gastroenterology Medicare: Medicare Enrolled Practice Location: 1211 Woodhurst St, Bowling Green, KY 42104 Phone: 270-782-7373 Fax: 270-796-8676 |
News Archive
Results from a study of patients with a diagnosis of mild cognitive impairment or early dementia indicates that their outlook isn't as dark as expected.
Infants and young children living in Baltimore's inner-city homes are at risk for serious perils, including fires, falls and poisoning, according to a small but revealing study from the Johns Hopkins Children's Center.
Pharmasset, Inc., announced today sustained virologic response (SVR) results from its phase 2b PROTON study with PSI-7977 400 mg dosed once daily in combination with peginterferon alfa 2a and ribavirin (Peg-IFN/RBV) in subjects with hepatitis C virus (HCV) genotype 1 who have not been treated previously. 43 out of 44 (98%) evaluable subjects achieved an SVR12, defined as HCV RNA below the limit of detection (<15 IU/mL) 12 weeks after the completion of treatment.
Alfuzosin, a drug commonly prescribed for men with chronic prostatitis, a painful disorder of the prostate and surrounding pelvic area, failed to significantly reduce symptoms in recently diagnosed men who had not been previously treated with this drug, according to a clinical trial sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH).
Ann Arbor-based Altarum Institute has been awarded a grant of $19,619,990 by the U.S. Department of Health and Human Services to serve as the lead agent in establishing Michigan's health information technology regional extension center, the Michigan Center for Effective IT Adoption (M-CEITA, www.mceita.org). The grant will be administered through the Office of the National Coordinator for Health Information Technology and managed and sponsored by Altarum. It is expected to create over 100 new jobs in Michigan.
› Verified 2 days ago